Novelgen
Find Us
← Back to list
Erasca data add to pressure facing Revolution’s breakthrough cancer drug

Erasca data add to pressure facing Revolution’s breakthrough cancer drug

BioPharma DiveJonathan GardnerNovember 20, 2026
Rasonque is already off to one of the best oncology launches in history. But certain limitations leave an opportunity that companies like Erasca which is nearing the start of a Phase 3 trial may be able to exploit.
Read original article
← Back to list